Proposal to Fund Lisdexamfetamine for Attention Deficit Hyperactivity Disorder

Submission Last updated: Sep 2024 Published in New Zealand Reference: 13NZ

RANZCP NZ Submission to Pharmac regarding the Proposal to Fund Lisdexamfetamine for Attention Deficit Hyperactivity Disorder

Resources

PDF (279 KB)